EUCTR2021-002712-30-ES进行中（未招募）1 期
PHASE III, RANDOMISED, DOUBLE-BLIND, CLINICAL TRIAL TO DETERMINE THE ROLE OF MAGNESIUM SULPHATE IN ADDUCTOR CANAL BLOCK IN ARTHROSCOPIC KNEE SURGERY
FUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD0 个研究点目标入组 131 人开始时间: 2021年7月29日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 131
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients scheduled for anterior cruciate ligament reconstruction surgery via arthroscopy.
- •- ASA I and II patients of both sexes.
- •- Age between 18 and 60 years.
- •- Signed informed consent form agreeing to participate in the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 131
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- ASA III or IV patients.
- •- Patients with expected difficult airway.
- •- Patients with the presence of predictive criteria for failed ventilation with supraglottic devices.
- •- Allergy or intolerance to local anaesthetics, morphine or derivatives, magnesium sulphate.
- •- Diabetes mellitus with last control of glycosylated haemoglobin greater than 7%.
- •- Patients with neuromuscular diseases.
- •- Patients with previous treatment with corticoids or calcium antagonists.
- •- Patients with difficulty in understanding the information related to the study and in collaborating in the assessment of pain.
- •- Patients with major psychiatric pathology in DSM-V.
- •- Pregnancy and/or breastfeeding.
研究者
相似试验
未知
不适用
MISSIOPER-007-13Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.,
已完成
不适用
A PHASE 3B, RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT SC IN COMBINATION WITH METHOTREXATE COMPARED TO METHOTREXATE MONOTHERAPY IN ACHIEVING CLINICAL REMISSION IN ADULTS WITH EARLY RHEUMATOID ARTHRITIS WHO ARE METHOTREXATE NAIVE-M05M05PER-041-15BRISTOL MYERS SQUIBB COMPANY,43
进行中（未招募）
1 期
INTRAVENOUS IMMUNOGLOBULIN HUMAN FOR THE TREATMENT OF ABORTIOrecurrent aborption with inmunological etiologyMedDRA version: 19.0Level: LLTClassification code 10072314Term: Pregnancy lossSystem Organ Class: 100000004868EUCTR2014-005419-18-ESsilvia sanchez ramon
进行中（未招募）
1 期
Perioperative treatment of locally advanced resectable gastric or GEJ adenocarcinomaGastric and gastroesophageal junction (GEJ) adenocarcinomaMedDRA version: 20.0Level: PTClassification code: 10001150Term: Adenocarcinoma gastric Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10066354Term: Adenocarcinoma of the gastroesophageal junction Class: 10029104CTIS2023-509595-42-00Merck Sharp & Dohme LLC1,122
进行中（未招募）
1 期
A Phase III, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) (SCH-900475) plus Chemotherapy (XP or FP) versus Placebo plus Chemotherapy (XP or FP) as Neoadjuvant/Adjuvant Treatment for Gastric or Gastroesophageal Junction Adenocarcinoma (KEYNOTE-585)Gastric or Gastroesophageal Junction AdenocarcinomaMedDRA version: 21.0Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 100000004864EUCTR2016-004408-76-LTMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.1,000